According to MarketsandMarkets, the Molecular Infectious Disease Testing Market is projected to grow from about USD 11.30 billion in 2026 to ...

MiRNA microarray kits and reagents market is experiencing robust growth driven by rising demand for precision diagnostics, biomarker discovery, and translational research. Expansion of oncology ...

NEW YORK – After having cut its teeth on the cannabis, food, and COVID-19 testing markets, PathogenDx is poised to launch a microarray-based test for urinary tract infections later this year. The new ...

Covid test kits are in short supply in the U.S. and scammers are taking advantage, according to the Federal Trade Commission, which issued an alert on Tuesday about bogus kits being sold to consumers ...

PathogenDx has announced the release of the first quantitative microarray-based test for cannabis, PDx-Quant™, which can determine whether or not a sample exceeds a state or a federal regulatory ...